Dermatology · Mobile, AL
NPI
1265666820
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
580 Providence Park Dr E, 2nd Floor
Mobile, AL, 36695
Phone (251) 631-3570
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
5,086 services
Medicare patients, 2024
806
Average age 74
Drug cost, 2024
$2.7M
2,168 prescriptions
Company payments, 2025
$3,617
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Virginia J Reeder was code 17003 (destruction skin lesion), 1,851 times for 290 patients. In total Virginia J Reeder billed 5,086 services in 46 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,851 | 290 | $4.48 | $8,284 |
| 99213 Office E&M - Established | Office | 865 | 531 | $57.25 | $50K |
| 17000 Destruction Skin Lesion | Office | 690 | 431 | $37.16 | $26K |
| 99214 Office E&M - Established | Office | 306 | 214 | $83.40 | $26K |
| 11102 Skin Biopsy | Office | 276 | 224 | $64.39 | $18K |
| 12032 Wound Repair - All Levels | Office | 96 | 84 | $205.03 | $20K |
| 11103 Skin Biopsy | Office | 89 | 49 | $34.10 | $3,035 |
| 17110 Destruction Skin Lesion | Office | 78 | 71 | $75.04 | $5,853 |
| 99203 Office E&M - New | Office | 78 | 78 | $68.62 | $5,352 |
| 11602 Skin Lesion Excision | Office | 56 | 50 | $89.79 | $5,028 |
| 17004 Destruction Skin Lesion | Office | 41 | 31 | $113.40 | $4,649 |
| 99212 Office E&M - Established | Office | 28 | 23 | $39.09 | $1,095 |
| 11603 Skin Lesion Excision | Office | 28 | 26 | $100.62 | $2,817 |
| 99211 Office E&M - Established | Office | 27 | 27 | $16.43 | $444 |
| 99204 Office E&M - New | Office | 24 | 24 | $92.89 | $2,229 |
By year: 2022 $152K for 3,817 services; 2023 $189K for 4,764 services; 2024 $195K for 5,086 services.
Medicare prescription drug claims, 2024
In 2024, the drug Virginia J Reeder prescribed most often to Medicare patients was Ketoconazole, with 483 prescriptions and refills. In total Virginia J Reeder wrote 2,168 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 483 | 508 | 230 | $8,046 |
| Clobetasol Propionate Generic | 345 | 367 | 220 | $16K |
| Triamcinolone Acetonide Generic | 245 | 282 | 191 | $4,707 |
| Doxycycline Hyclate Generic | 92 | 95 | 56 | $1,311 |
| Tacrolimus Generic | 91 | 96 | 63 | $13K |
| Hydrocortisone Generic | 90 | 98 | 71 | $471 |
| Metronidazole Generic | 55 | 59 | 33 | $5,166 |
| Dupixent Pen Dupilumab | 54 | 55 | 11 | $222K |
| Cosentyx Unoready Pen Secukinumab | 52 | 52 | Under 11 | $618K |
| Valacyclovir Valacyclovir Hcl | 46 | 54 | 21 | $1,490 |
| Hydroxychloroquine Sulfate Generic | 35 | 59 | Under 11 | $1,729 |
| Fluorouracil Generic | 32 | 33 | 30 | $2,374 |
| Humira(Cf) Pen Adalimumab | 29 | 29 | Under 11 | $387K |
| Tretinoin Generic | 28 | 28 | 23 | $1,754 |
| Rinvoq Upadacitinib | 25 | 25 | Under 11 | $174K |
Brand drugs: 329 claims; generic drugs: 1,839 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Virginia J Reeder $3,617 ($3,617 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $626.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 46 | $626 |
| Janssen Biotech, Inc. JNJ | 27 | $534 |
| UCB, Inc. UCB.BR | 17 | $386 |
| Novartis Pharmaceuticals Corporation NVS | 25 | $361 |
| Incyte Corporation INCY | 16 | $247 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 19 | $244 |
| LEO Pharma Inc. | 17 | $224 |
| Lilly USA, LLC LLY | 9 | $188 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $156 |
| Pfizer Inc. PFE | 10 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.